Table 3.
Comparison of Clinical Characteristics Between Patients With and Without LA Enlargement
| Without LA Enlargement (n=146) | With LA Enlargement (n=195) | P Value | |
|---|---|---|---|
| Age, y | 56±15.0 | 63±13.2 | .001 |
| Male sex, % | 63.0 | 62.1 | .78 |
| Median duration of hypertension, y | 4.5 | 9.0 | .006 |
| BMI, kg/m2 | 24.23±3.57 | 25.85±3.75 | .004 |
| Waist circumference, cm | 86.4±7.71 | 91.2±8.81 | .003 |
| Total cholesterol, mmol/L | 5.22±1.15 | 5.31±1.21 | .14 |
| HDL‐C, mmol/L | 1.22±0.30 | 1.17±0.30 | .13 |
| Triglycerides, mmol/L | 1.64±0.75 | 1.76±0.67 | .02 |
| FPG, mg/dL | 93.6±19.98 | 97.2±24.84 | .15 |
| SBP, mm Hg | 172±19.9 | 177±25.1 | .050 |
| DBP, mm Hg | 105±15.4 | 104±13.9 | .53 |
| Metabolic syndrome, % | 32.19 | 49.74 | .003 |
| LVDd, cm | 4.5±0.41 | 5.0±0.64 | .005 |
| LVEF, % | 66.7±6.52 | 63.4±11.2 | .15 |
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL‐C, high‐density lipoprotein cholesterol; LA, left atrial; LVDd, left ventricular end‐diastolic dimension; LVEF, left ventricular ejection fraction; SBP, systolic blood pressure.
Categorical variables are presented as absolute (relative) frequencies and continuous variables as mean±standard deviation or median (interquartile range).